Gemcitabine vs cisplatin in patients with locally advanced head and neck cancer who are also receiving radiotherapy
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2012
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2012 New trial record
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 01 Jun 2011 Primary endpoint 'Progression-free-survival-duration' has been met.